BioCentury
ARTICLE | Distillery Therapeutics

A modified CRISPR adenine base editor with a minimal PAM requirement for DMD

July 2, 2021 9:40 PM UTC

DISEASE CATEGORY: Musculoskeletal

INDICATION: Muscular dystrophy...

BCIQ Company Profiles

Ohio State University

BCIQ Target Profiles

Dystrophin